Stockscreener 앱 받기
2.90
4.69%
0.13
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
NeOnc Technologies Holdings, Inc. (NTHI) stock price, news, quote and history - Yahoo Finance UK
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi - GlobeNewswire Inc.
Two Abu Dhabi children are receiving an investigational brain cancer treatment; a third is expected to join this week. - Stock Titan
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors - GlobeNewswire Inc.
NeOnc Technologies Announces FDA Meeting on November 17, 2026, for NEO212 Progress - Kalkine Media
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Canada
Form 4 Neonc Technologies Holdings Inc For: 27 September - Investing.com India
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Australia
Neonc Technologies CFO Garnett sells $16,809 stock - Investing.com
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com UK
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com UK
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier - GlobeNewswire Inc.
[8-K] NEONC TECHNOLOGIES HOLDINGS, INC. Reports Material Event - Stock Titan
NeOnc Charting New Nasal Route to Treating Brain Cancer - GlobeNewswire Inc.
Neonc Technologies CFO sells $16,809 in company stock - Investing.com
NeOnc Technologies (NTHI) CFO sells shares under preset plan - Stock Titan
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution - Yahoo Finance
A $6 million payment kept NeOnc from issuing new shares - Stock Titan
NeOnc leaders (NTHI) keep buying after positive Phase 2a data - Stock Titan
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results - TradingView
Neonc technologies CEO Thomas Chen buys $39,999 in stock - Investing.com
Neonc technologies CEO Amir Heshmatpour acquires $174,795 in stock - Investing.com
NeOnc Technologies (NTHI) CEO is buying more of his own stock - Stock Titan
NeOnc Technologies (NTHI) CFO adds shares in open-market buy - Stock Titan
NeOnc (NTHI) CEO adds shares in IRA trades - Stock Titan
NeOnc Technologies (NTHI) insider may sell $18,900 in stock - Stock Titan
48.9% had no cancer progression at six months in NeOnc’s 24-person study - Stock Titan
Neonc Technologies CEO Amir Heshmatpour buys $135,619 in shares - Investing.com
NeOnc (NTHI) CEO now holds 3.13M shares after stock buy - Stock Titan
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Nigeria
NeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout - AllSci
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com India
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com UK
NeOnc Technologies Launches $15 Million Registered Direct Offering at $4.20 With Warrants - TradingView
NeOnc Technologies Company Profile & Introduction - Moomoo
NeOnc Technologies Holdings Secures $15 Million Registered Direct Offering After Positive Phase 2a Data and Insider Buying - Quiver Quantitative
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data - marketscreener.com
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Stocktwits
NeOnc Technologies prices $15M registered direct offering - investing.com
NeOnc Technologies prices $15M registered direct offering By Investing.com - Investing.com Canada
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 - GlobeNewswire
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Yahoo Finance
Cancer-drug developer NeOnc plans a stock sale of about $15 million - Stock Titan
In a brain-cancer trial, 48.9% had no worsening at six months. NeOnc also redeemed $6M in stock. - Stock Titan
4.38%
1.00%
자본화:
|
볼륨(24시간):